UK Markets closed

Silence Therapeutics plc (SLNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
7.09+0.43 (+6.46%)
At close: 03:06PM EST
Full screen
Trade prices are not sourced from all markets
Previous close6.66
Bid0.00 x 0
Ask0.00 x 0
Day's range7.09 - 7.09
52-week range6.39 - 9.25
Avg. volume290
Market cap636.574M
Beta (5Y monthly)1.09
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Simply Wall St.

    Silence Therapeutics (LON:SLN) shareholders have earned a 36% CAGR over the last five years

    Silence Therapeutics plc ( LON:SLN ) shareholders might be concerned after seeing the share price drop 16% in the last...

  • Motley Fool

    Silence Therapeutics plc (SLN) Q2 2021 Earnings Call Transcript

    Joining me today on the call are Mark Rothera, our president and CEO, who will provide an update on the business; Dr. Giles Campion, our head of R&D and chief medical officer, who will provide an update on our clinical programs; and Craig Tooman, our chief financial officer, who will review our financials before opening the call to your questions. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in our most recent annual report on file with the SEC.

  • Motley Fool

    Silence Therapeutics Plc (SLN) Q4 2020 Earnings Call Transcript

    Image source: The Motley Fool. Silence Therapeutics Plc  (NASDAQ: SLN)Q4 2020 Earnings CallMar 30, 2021, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, ladies and gentlemen, and welcome to the Silence Therapeutics full-year 2020 conference call and webcast.